Latest Health News

Alcidion Group Limited has reported a robust start to FY26, posting $8.2 million in new sales and significantly improving its operating cash flow. The company reaffirms its guidance for positive EBITDA and cash flow for the full year.

Coronado Global Resources has proposed a significant financial support transaction with Stanwell Corporation, aiming to enhance liquidity, extend coal supply agreements, and support Queensland’s energy needs and local employment.

EMVision Medical Devices has expanded its pivotal clinical trial sites, secured a $3 million government grant, and raised $14 million through placement and share purchase plan, positioning itself strongly for upcoming regulatory submissions and commercialisation.

Coast Entertainment’s Dreamworld development application has been called-in by the Queensland Minister, while the company reports robust FY26 trading growth and nears completion of its new King Claw ride.

Talius Group has raised $4 million in a recent placement, expanding its subscription base and preparing to capitalize on new aged care legislation set to take effect in November 2025.

Proteomics International Laboratories has secured ISO 15189 certification and launched PromarkerD and PromarkerEso nationally in Australia, while advancing US reimbursement pathways and preparing for leadership transition.

Mt Malcolm Mines NL has announced a $2.3 million renounceable rights issue priced at 1.5 cents per share, aiming to fund exploration and development at its Malcolm Gold Project while strengthening its financial position.

Artrya Limited has secured FDA clearance for its Salix Coronary Plaque module and raised $80 million to fuel its U.S. commercial expansion, marking a pivotal step in its transition from development to revenue generation.

Emyria reports strong revenue growth driven by expanded insurer-funded mental health programs, marking a significant step in national access to evidence-based PTSD and treatment-resistant depression care.

OpenLearning Limited reports a strong Q3 FY25 with SaaS ARR up 27% year-on-year and a successful $2.6 million capital raise, positioning the company for cash flow breakeven within 18 months.

AnteoTech Ltd reports strong quarterly progress with a key US joint development agreement, significant manufacturing scale-up, and expanded market access in South Korea, underpinning its 2025 commercialisation strategy.

AML3D Limited reported steady quarterly receipts alongside a landmark US Navy Letter of Intent and significant orders, underpinning a major growth phase in the US and Europe.